Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference

NCT01403376 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01403376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01403376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
January 31, 2012
Enrollment
128 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis